The DCT Reality Check: Quantifying Technology Adoption in Modern Clinical Trial

Decentralized clinical trials have evolved from experimental concepts to mainstream approaches, driven by pandemic necessities and evolving participant expectations. However, the reality of DCT implementation often differs significantly from initial promises, with varying degrees of technology adoption, participant engagement, and operational success across different therapeutic areas and study populations.

Join us to discuss:

• What quantitative evidence exists around DCT technology adoption rates, participant engagement, and study efficiency compared to traditional trial approaches?
• Which DCT components and technologies are demonstrating measurable value, and where are we seeing persistent implementation challenges or participant resistance?
• How can sponsors and CROs use real-world DCT performance data to make more informed decisions about technology selection and hybrid trial design?